241 related articles for article (PubMed ID: 30218283)
21. The role of vagal function in the risk for cardiovascular disease and mortality.
Thayer JF; Lane RD
Biol Psychol; 2007 Feb; 74(2):224-42. PubMed ID: 17182165
[TBL] [Abstract][Full Text] [Related]
22. A theoretical appraisal of the dependence of respiratory sinus arrhythmia on gradual vagal blockade.
Pyetan E; Akselrod S
Methods Inf Med; 2004; 43(1):52-5. PubMed ID: 15026837
[TBL] [Abstract][Full Text] [Related]
23. Blocking effects of alinidine on negative chronotropic and inotropic responses to vagal stimulation and injected acetylcholine and carbachol in dogs.
Ogiwara Y; Furukawa Y; Takeda M; Chiba S
J Pharmacol Exp Ther; 1987 Dec; 243(3):1113-20. PubMed ID: 3694527
[TBL] [Abstract][Full Text] [Related]
24. [The role of different mechanisms of cholinergic regulation in controlled bradycardia evoked by vagal stimulation].
Osadchiĭ OE; Pokrovskiĭ VM
Ross Fiziol Zh Im I M Sechenova; 1999 May; 85(5):637-45. PubMed ID: 10511982
[TBL] [Abstract][Full Text] [Related]
25. Peripheral muscarinic control of norepinephrine release in the cardiovascular system.
Muscholl E
Am J Physiol; 1980 Dec; 239(6):H713-20. PubMed ID: 7192494
[TBL] [Abstract][Full Text] [Related]
26. Tonically Active cAMP-Dependent Signaling in the Ventrolateral Medulla Regulates Sympathetic and Cardiac Vagal Outflows.
Tallapragada VJ; Hildreth CM; Burke PG; Raley DA; Hassan SF; McMullan S; Goodchild AK
J Pharmacol Exp Ther; 2016 Feb; 356(2):424-33. PubMed ID: 26578265
[TBL] [Abstract][Full Text] [Related]
27. beta-Bungarotoxin and parasympathetic nerve blocking action.
Muramatsu I; Fujiwara M; Miura A; Hayashi K; Lee CY
J Pharmacol Exp Ther; 1980 Apr; 213(1):156-60. PubMed ID: 7359364
[TBL] [Abstract][Full Text] [Related]
28. Sympathetic afferent stimulation inhibits central vagal activation induced by intravenous medetomidine in rats.
Kawada T; Akiyama T; Shimizu S; Kamiya A; Uemura K; Turner MJ; Shirai M; Sugimachi M
Acta Physiol (Oxf); 2013 Sep; 209(1):55-61. PubMed ID: 23710753
[TBL] [Abstract][Full Text] [Related]
29. Catecholamines abolish vagal but not acetylcholine tone in the intact cat trachea.
Baker DG; Don H
J Appl Physiol (1985); 1987 Dec; 63(6):2490-8. PubMed ID: 2830220
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
[TBL] [Abstract][Full Text] [Related]
31. Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning.
Donato M; Buchholz B; Rodríguez M; Pérez V; Inserte J; García-Dorado D; Gelpi RJ
Exp Physiol; 2013 Feb; 98(2):425-34. PubMed ID: 22872660
[TBL] [Abstract][Full Text] [Related]
32. Sympathetic control of short-term heart rate variability and its pharmacological modulation.
Elghozi JL; Julien C
Fundam Clin Pharmacol; 2007 Aug; 21(4):337-47. PubMed ID: 17635171
[TBL] [Abstract][Full Text] [Related]
33. Possibilities for a cholinergic action on smooth musculature and on sympathetic axons in brain vessels mediated by muscarinic and nicotinic receptors.
Edvinsson L; Falck B; Owman C
J Pharmacol Exp Ther; 1977 Jan; 200(1):117-26. PubMed ID: 833753
[TBL] [Abstract][Full Text] [Related]
34. The cholinergic system in cyclophosphamide-induced Chagas dilated myocardiopathy in Trypanosoma-cruzi-infected rats: an electrocardiographic study.
Labrador-Hernández M; Suárez-Graterol O; Romero-Contreras U; Rumenoff L; Rodríguez-Bonfante C; Bonfante-Cabarcas R
Invest Clin; 2008 Jun; 49(2):207-24. PubMed ID: 18717267
[TBL] [Abstract][Full Text] [Related]
35. Effects of tertiapin-Q and ZD7288 on changes in sinoatrial pacemaker rhythm during vagal stimulation.
Han SY; Bolter CP
Auton Neurosci; 2015 Dec; 193():117-26. PubMed ID: 26549880
[TBL] [Abstract][Full Text] [Related]
36. Ambiguous effect of signals transmitted by the vagus nerve on fibrosarcoma incidence and survival of tumor-bearing rats.
Mikova L; Horvathova L; Ondicova K; Tillinger A; Vannucci LE; Bizik J; Gidron Y; Mravec B
Neurosci Lett; 2015 Apr; 593():90-4. PubMed ID: 25797182
[TBL] [Abstract][Full Text] [Related]
37. Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.
Franco CCS; Prates KV; Previate C; Moraes AMP; Matiusso CCI; Miranda RA; de Oliveira JC; Tófolo LP; Martins IP; Barella LF; Ribeiro TA; Malta A; Pavanello A; Francisco FA; Gomes RM; Alves VS; Moreira VM; Rigo KP; Almeida DL; de Sant Anna JR; Prado MAAC; Mathias PCF
Endocrine; 2017 May; 56(2):346-356. PubMed ID: 28233096
[TBL] [Abstract][Full Text] [Related]
38. [Peptide correction of arrhythmias induced by stimulation of the vagal sympathetic trunk in cats].
Osadchiĭ OE; Pokrovskiĭ VM
Patol Fiziol Eksp Ter; 1997; (3):10-3. PubMed ID: 9312711
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis.
Kanashiro A; Sônego F; Ferreira RG; Castanheira FV; Leite CA; Borges VF; Nascimento DC; Cólon DF; Alves-Filho JC; Ulloa L; Cunha FQ
Pharmacol Res; 2017 Mar; 117():1-8. PubMed ID: 27979692
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid treatment increases inhibitory m(2) muscarinic receptor expression and function in the airways.
Jacoby DB; Yost BL; Kumaravel B; Chan-Li Y; Xiao HQ; Kawashima K; Fryer AD
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):485-91. PubMed ID: 11306443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
